Background Neurostimulation of the subthalamic nucleus reduces levodopa-related motor
complications in advanced Parkinson's disease. We compared this treatment plus medication …

The prevalence of falls among neurological patients is unknown, although disturbances of
gait and posture are common. Falls may lead to burdens for the patient, the caregivers and …

Importance While mutations in glucocerebrosidase (GBA1) are associated with an increased
risk for Parkinson disease (PD), it is important to establish whether such mutations are also …

Autosomal-recessive early-onset parkinsonism is clinically and genetically heterogeneous.
The genetic causes of approximately 50% of autosomal-recessive early-onset forms of …

Objective Hereditary spastic paraplegias (HSPs) are genetically driven disorders with the
hallmark of progressive spastic gait disturbance. To investigate the phenotypic spectrum, …

Phosphorylated alpha-synuclein (p-alpha-syn) deposits, one of the neuropathological hallmarks
of Parkinson’s disease (PD), have recently been detected in dermal nerve fibres in PD …

Objective To investigate the longitudinal dose-effect relationship between dopamine replacement
therapy and impulse control disorders (ICDs) in Parkinson disease (PD). Methods We …

GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine
production in nigrostriatal cells. Loss-of-function mutations in GCH1 result in severe reduction …

Hereditary spastic paraplegias (HSPs) are genetically determined neurodegenerative
disorders characterized by progressive weakness and spasticity of lower limbs, and are among …

Mutations in the spastic paraplegia 7 (SPG7) gene encoding paraplegin are responsible for
autosomal recessive hereditary spasticity. We screened 135 unrelated index cases, selected …